Submitted by roany98@gmail.com on Wed, 07/19/2023 - 14:33
Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)
Aditya Bardia, MD, MPH
Director, Breast Cancer Research Program
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts
Director, Breast Cancer Research Program
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts
Erika Hamilton, MD
Director, Breast Cancer Research Program
Sarah Cannon Research Institute/Tennessee Oncology
Nashville, Tennessee